coronary artery bypass graft surgery (CABG), (2) presence of significant stenosis (>75%) by CAG and treated with antianginal agents (eg, blocker, calcium channel blocker, aspirin, nitrate); (3) history of myocardial infarction (MI).
Coronary Angiography
All patients were admitted to hospital the day before CAG. The purpose of CAG was one or more of the following: (1) chronic phase or follow-up of acute MI (n=158), (2) follow-up of PCI and/or CABG (n=78) or (3) diagnosis of ischemic conditions, such as angina of effort (n=44). After administration of isosorbide dinitrate (2.5-5 mg, bolus dose), the coronary artery was evaluated by 2 cardiologists who were unaware of the patient profiles, and narrowing ≥75% was judged to be significant.
Definition of New CAD
Follow-up coronary angiography was performed in patients in whom new CAD was suspected from symptoms and/or the electrocardiogram (ECG). Clinical presentation was categorized as ECG abnormality (stress ECG positive only), stable angina (stable exertional symptoms only), unstable angina (progressive symptoms or symptoms at rest), or MI (creatine kinase [CK] level >636 IU/L and creatine kinase-myocardial band isoenzyme [CK-MB] index >6%). When significant coronary narrowing (ie, ≥75%) was confirmed and the narrowing of the same lesion had been less than 50% on CAG at the time of enrollment in the study, it was diagnosed as new CAD. However, when the narrowed lesion was a restenosis of the PCI site, it was excluded from the new CAD grouping.
Definition of CVE Other Than CAD
The presence of CVE other than CAD was evaluated from appropriate clinical information. Cerebrovascular disease was diagnosed on the basis of previous positive findings of infarction or bleeding, by X-ray computed tomography or magnetic resonance. Diagnosis of aortic aneurysm and aortic dissection was made by X-ray computed tomography or aortography. Congestive heart failure was diagnosed by chest X-ray, echocardiography and the presence of arterial blood hypoxemia.
Definition of History of Hypertension
Blood pressure (BP) was measured in the morning of admission, using a standard mercury sphygmomanometer and cuffs adapted to arm circumference, after the patient had rested in the supine position for at least 5 min. Systolic and diastolic BP were taken at the points of appearance and disappearance, respectively, of the Korotkoff sounds. The average of 3 measurements was used for analysis. Hypertension was diagnosed by the presence of one or more of the following: 12 (1) systolic BP >140 mmHg, (2) diastolic 
Blood Sampling and Assay
Blood was drawn in the morning after an overnight fast of at least 12 h. Whole blood was used for hemoglobin A1c, EDTA-plasma for glucose, insulin and lipids, and serum for other biochemical assays. Glucose was measured by the glucose oxidase method. Plasma concentrations of glucose were measured by a Glucorder analyzer (Analytical Instrument Co, Tokyo, Japan). Plasma concentrations of insulin were measured by radioimmunoassay using an AIA-21 (Tosou Co, Yamaguchi, Japan). Total cholesterol and triglycerides were measured enzymatically, high-density lipoprotein cholesterol (HDL-C) was measured after precipitating apolipoprotein B-containing lipoproteins with dextran sulfate and magnesium chloride, and low-density lipoprotein cholesterol was calculated according to the Friedwald formula. Other measurements were done by routine methods.
Oral Glucose Tolerance Test
A fasting blood sample from each patient was obtained in the morning after a fast of at least 12 h. A 75-g glucose solution was given orally. Blood samples were obtained at baseline and 2 h after the glucose load. Concentrations of glucose and insulin in plasma were determined at these time points. According to the recommendation of the World Health Organization on the diagnosis of diabetes mellitus, patients were diagnosed as having normal glucose tolerance (NGT) when baseline plasma glucose was <110 mg/dl and plasma glucose 2 h after the glucose load was <140 mg/dl.
Assessment of Insulin Resistance Using the Homeostasis Model Assessment (HOMA-IR)
Insulin resistance was assessed using the HOMA-IR originally described by Matthews et al. 13 HOMA-IR was calculated using the following formula:
HOMA-IR (mg/dl × U/ml) = fasting glucose (mg/dl) × fasting insulin ( U/ml)/405.
HOMA-IR has a close correlation with the insulin sensitivity index by the standard euglycemic hyperinsulinemic clamp, as shown by Matthews et al. 13 
End-Point of This Study
Primary outcome was new CAD or new CVD at or before February 28, 2003.
Statistical Analyses
Continuous variables were summarized as mean ± SD. Prognostic variables for survival were first examined using the univariate Cox proportional hazards regression models, and all variables were forced into the multivariate Cox model. p<0.05 was considered significant. Analyses were performed using statistical software (StatView 5; SAS Institute, Inc, Cary, NC, USA) for Macintosh personal computers. Table 1 shows the clinical characteristics of the 102 enrolled patients. Twenty-three patients had new CVE; they had significantly higher fasting and post-OGTT insulin concentrations and HOMA-IR than those without new CVE (p<0.01, 0.031 and <0.01, respectively). The use of medications did not differ significantly between those having and not having new CVE. Table 2 shows the outcomes in the 23 patients with new CVE: 19 had new CAD and 4 had a new CVE other than CAD; 14 patients underwent PCI, 1 had coronary artery bypass graft surgery, and 4 underwent pharmacotherapy. Among the 4 new CVD cases, there were 2 deaths (sudden cardiac death, 1; thoracic aortic aneurysm rupture, 1), 1 abdominal aortic aneurysm and 1 stroke. Table 3 shows the characteristics of 20 lesions in 19 patients with new CAD. New significant narrowing confirmed by CAG was found in 8 lesions in the right coronary artery, 2 in the left main trunk, 6 in the left anterior descending artery, 3 in the left circumflex artery and 1 in a saphenous vein graft. Progression from a normal coronary artery was found in only 2 of the 20 lesions. It seems that there was mild or moderate arteriosclerosis in many of the coronary arteries, which contributed to the new onset of CAD from the time of enrollment.
Results

Patient Characteristics and Outcome Data Collection
Univariate Association Between New CVE and Fasting Plasma Insulin, Plasma Insulin 2 h After 75-g Glucose Load and HOMA-IR
In the analyses, fasting plasma insulin, plasma insulin 2 h after 75-g glucose load, HOMA-IR and HDL-C were found to be significant univariate risk factors of new CVE (Table 4) .
Independent Predictors of CVE
Independent predictors of new CVE were identified by multivariate Cox models (Table 5) . Fasting plasma insulin, plasma insulin 2 h after 75-g glucose load, HOMA-IR and 
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HDL-C were significant univariate risk factors. All variables except HDL-C were related to plasma insulin concentrations. Therefore, we examined whether the effect of fasting plasma insulin, plasma insulin 2 h after 75-g glucose load and HOMA-IR on new CVE was independent of HDL-C and the common unfavorable factors (ie, dyslipidemia, hypertension, history of MI, multivessel disease, smoking, male gender, obesity, age). Fasting plasma insulin and HOMA-IR remained significant and independent of HDL-C and other covariates.
Discussion
Insulin resistance is significant in the cluster of risk factors for atherosclerosis, such as hypertension, dyslipidemia, and abnormal glucose metabolism. Many, [8] [9] [10] [11] [14] [15] [16] [17] [18] [19] [20] [21] [22] but not all studies, 23, 24 of the general population show a positive association of the indices of insulin resistance with arterial wall changes, CAD, and CVD. In the present study, we revealed that HOMA-IR, an index of insulin resistance, was an independent risk factor of new CVE in study patients with prior CAD. The clustering of risk factors synergistically increases the risk of atherosclerosis. 25 The current hypothesis of 'multiple risk factor syndrome' is that insulin resistance is an important mechanism for the clustering of hypertension, dyslipidemia, and abnormal glucose metabolism. [26] [27] [28] [29] We therefore expected that the association between HOMA-IR and new CVE would be dependent on these risk factors and that the association would become insignificant when these individual risk factors were included in the multivariate Cox model. However, the association between HOMA-IR and new CVE remained significant and independent of these major risk factors. There is a possible explanation for this observation. Because Cox analysis evaluated the independent effect of individual risk factors on new CVE, the synergistic effect of these risk factors may have been reflected in the significant association with insulin resistance, a common basis for the multiple risk factors.
In the present study, the first important finding was that high HOMA-IR was a significant risk factor of new CVE. Insulin resistance and the other risk factors may have different roles in the development of new CVE in a population with prior CAD.
Secondly, we found that fasting hyperinsulinemia was an independent risk factor of new CVE. The plasma insulin 2 h after glucose loading was not an independent risk factor by multivariate analysis. However, in patients with new CVE, the plasma insulin level 2 h after glucose loading was significantly higher than in patients without new CVE. This shows that in the new CVE patients the plasma insulin concentration was high each time the blood was sampled. The presence of hyperinsulinemia after fasting and at 2 h after glucose loading may therefore serve as a crude, but clinically relevant marker for other metabolic and hemostatic disturbances; namely, visceral obesity, a procoagulant state, and alterations in growth factor concentrations, all of which are associated with an increased risk of ischemic heart disease. 30 Haffner and Meittinen noted that endogenous insulin usually increased the effect of cardiovascular risk factors and that the macrovascular complications start earlier than the microvascular ones. 31 However, laboratory standardization of insulin measurements remains a problem, and there is currently no universally accepted criterion for the definition of hyperinsulinemia in either the fasting state and or 2 h after glucose loading.
Study Limitations
The results did not show an association between the well-known risk factors for new CVE. The number of new CVE was relatively small, and the statistical power may not have been large enough to detect important cardiovascular risk factors such as hypertension and dyslipidemia.
In conclusion, this investigation revealed that insulin resistance and fasting hyperinsulinemia were independent risk factors of new CVE in patients with prior CAD and NGT. Because an insulin-resistant, hyperinsulinemic state increases the risk of type II diabetes mellitus, 32 our results also support the notion that maintaining an adequate level of insulin sensitivity and low plasma insulin concentrations through active intervention in patients with prior CAD (eg, through proper diet and exercise) not only may be of value in preventing type II diabetes, but may also reduce the risk of CVE. 32 This would apply even to patients with normal glucose tolerance. Thus, attention to maintaining insulin sensitivity and low plasma insulin concentrations may be a new strategy in the treatment of these patients.
